Gerald D. Cagle, Director at AERIE PHARMACEUTICALS INC (AERI), bought 1,000 shares at $50.25 ($50K) on 2018-05-21, disclosed to the SEC on 2018-05-22.
Open-market purchase of $50k AERI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| AERI | BUY | 2018-05-25 | $49K | — | Filing → |
| CLSD | BUY | 2018-03-23 | $89K | — | Filing → |
| CLSD | BUY | 2017-08-15 | $35K | — | Filing → |